Salud
La sospecha de falsificación de Ozempic obliga a hospitalizar a varias personas en Austria
Several people were hospitalised in Austria after consuming suspected counterfeit versions of the diabetes drug Ozempic, the country’s health safety agency said. The patients suffered
Nestlé comienza a trabajar en 'productos complementarios' para medicamentos para bajar de peso
Nestle on Thursday said it has started work on products that will “complement” weight-loss drugs such as Novo Nordisk’s revolutionary Wegovy, hoping to capitalise on
El regulador europeo advierte a la UE y al Reino Unido sobre las plumas Ozempic falsificadas
The European medicines regulator on Wednesday warned of pre-filled pens falsely labelled as Novo Nordisk’s popular diabetes drug Ozempic at wholesalers in the European Union
Pfizer fijará el precio del tratamiento COVID-19 con Paxlovid en $1390 por curso
Pfizer on Wednesday said it would set the U.S. price for its COVID-19 antiviral drug Paxlovid at nearly $1400 for a five-day course when the
Hyloris Pharma ha recibido la aprobación de la FDA de EE. UU. para su tratamiento del dolor
US health regulators have approved Hyloris Pharmaceuticals’ drug for post-operative pain, the Belgian company said on Wednesday, adding that it expects to launch the non-opioid
El regulador de la UE apoya el uso del fármaco de Merck para tratar infecciones virales
Merck & Co said the European Union’s medicines regulator has recommended a registration authorisation for the company’s Prevymis drug to treat a type of infection
Keytruda de Merck ha recibido la aprobación de la FDA para ampliar su uso en el cáncer de pulmón
The US Food and Drug Administration has approved the expanded use of Merck & Co’s blockbuster immunotherapy Keytruda in early-stage patients with non-small cell lung
Omeros detiene el desarrollo de una terapia para la enfermedad renal después de que el estudio fracasa
Omeros Corp. said Monday it will stop developing an experimental therapy to treat a certain type of kidney disease after a late-stage study failed and
Italia cobrará a los extranjeros 2.000 euros al año por atención médica
Foreigners living in Italy will be able to use the national health service after paying an annual fee of 2,000 euros ($2,109), the government said
Labcorp lanza análisis de sangre de tres pasos para la enfermedad de Alzheimer
Labcorp has begun selling U.S. doctors the first test for three blood biomarkers they say can detect signs of Alzheimer’s disease, speeding diagnosis of the